Literature DB >> 22637214

Long-term outcomes of lumbar posterior apophyseal end-plate lesions in children and adolescents.

Kosaku Higashino1, Koichi Sairyo, Shinsuke Katoh, Shyoichiro Takao, Hirofumi Kosaka, Natsuo Yasui.   

Abstract

BACKGROUND: A lesion of the lumbar posterior apophyseal end plate in children and adolescents causes symptoms similar to those associated with a herniated disc. However, the end-plate lesion and the herniated disc differ in terms of pathology. The purpose of this study was to clarify the long-term clinical and radiographic outcomes in children and adolescents who were treated either surgically or conservatively for a lumbar posterior apophyseal end-plate lesion.
METHODS: We identified twenty-four consecutive patients who had been treated in the sports clinic of our hospital. The mean age at the first medical examination was 14.5 years. The mean follow-up time was 13.8 years. The mean age at the time of final follow-up was 28.4 years. All twenty-four patients had symptomatic low back pain with sciatica. All but two were active in sports. Sixteen patients were treated conservatively, and eight patients underwent surgical intervention. Skeletal maturity was evaluated on the basis of the appearance of the secondary ossification center of L3.
RESULTS: The apophyseal stage ("A" stage), which was assigned when the secondary ossification center of the vertebral body was visible on radiographs, was seen most frequently. Both the surgically treated group and the conservatively treated group demonstrated progressive disc degeneration at the involved level. The average Roland-Morris Disability Questionnaire (RDQ) score was 1.3 for the patients treated conservatively and 1.8 for those treated surgically, a nonsignificant difference. One patient developed spinal stenosis after twelve years of conservative treatment. One patient treated surgically demonstrated severe lumbar instability. There were no significant associations between the magnetic resonance imaging (MRI) findings and RDQ scores. Histological examination of surgical specimens showed irregular alignment of the anulus fibrosus, with degenerative matrix and chondrocytes without a nucleus.
CONCLUSIONS: The long-term outcome for patients with a posterior end-plate lesion is favorable, regardless of whether it is treated surgically or nonsurgically.

Entities:  

Mesh:

Year:  2012        PMID: 22637214     DOI: 10.2106/JBJS.K.00343

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  5 in total

1.  Study of lesions of the lumbar endplate based on the stage of maturation of the lumbar vertebral body: the relationship between skeletal maturity and chronological age.

Authors:  Hideyuki Uraoka; Kosaku Higashino; Masatoshi Morimoto; Kazuta Yamashita; Fumitake Tezuka; Yoichiro Takata; Toshinori Sakai; Akihiro Nagamachi; Masaaki Murase; Koichi Sairyo
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-09-16

Review 2.  Back Pain in Children- How Sinister?

Authors:  Pankaj Kandwal; G Vijayaraghavan; Ankur Goswami; Arvind Jayaswal
Journal:  Indian J Pediatr       Date:  2015-09-28       Impact factor: 1.967

3.  Recurrence of type I Modic inflammatory changes in the lumbar spine: effectiveness of intradiscal therapy.

Authors:  Kazuaki Mineta; Kosaku Higashino; Toshinori Sakai; Yoshihiro Fukui; Koichi Sairyo
Journal:  Skeletal Radiol       Date:  2014-07-09       Impact factor: 2.199

4.  A Rare Case of Progressive Palsy of the Lower Leg Caused by a Huge Lumbar Posterior Endplate Lesion after Recurrent Disc Herniation.

Authors:  Masatoshi Morimoto; Kosaku Higashino; Shinsuke Katoh; Tezuka Fumitake; Kazuta Yamashita; Fumio Hayashi; Yoichiro Takata; Toshinori Sakai; Akihiro Nagamachi; Koichi Sairyo
Journal:  Case Rep Orthop       Date:  2016-08-28

Review 5.  Outcome Instruments in Spinal Trauma Surgery: A Bibliometric Analysis.

Authors:  Holt S Cutler; Javier Z Guzman; James Connolly; Motasem Al Maaieh; Branko Skovrlj; Samuel K Cho
Journal:  Global Spine J       Date:  2016-03-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.